首页> 外文会议>Proceedings '96 China-Japan symjposium on particuology >PERCOLATION THEORY AND ROBUST FORMULATIONS IN POWDER TECHNOLOGY
【24h】

PERCOLATION THEORY AND ROBUST FORMULATIONS IN POWDER TECHNOLOGY

机译:粉末技术中的渗透理论和鲁棒公式

获取原文

摘要

Pharmaceutical solid dosage forms (tablets, dragees, capsules) represent the majority of all dosage forms on the market. To guarantee a high quality of these dosage forms robust formulations are a prerequisite. Thus, a formulation which describes the composition and the process needs to be validated. Due to the complexity of a pharmaceutical formulation, the high number of factors, which may affect the quality of the dosage form, most of the knowledge concerning the use of pharmaceutical powder mixtures is based on empirical findings. Percolation theory seems to offer a key for a more rational design of formulations consisting of particulate material. Two typical applications will be presented: a fast-disintegrating water-soluble tablet formulation and a non-swellable matrix-type controlled release system which does not disintegrate. The application of the concepts of percolation theory, which is useful in very different areas, such as phase transitions in solids, diffusion in disordered media, etc., leads to an important insight in the behaviour of the fast-disintegrating and the non-disintegrating solid dosage forms. The fundamental equation of percolation theory can be applied in both cases. The equation is a power law which describes the relevant property X of the system studied close to the percolation theshold p_c as follows X = S/p-p_c/q (1) with S = Scaling factor, p = occupation probability and q = critical exponent The occupation probability in a particulate system corresponds in general to the concentration of the relevant component, such as the disintegrant in the fast-disintegrating tablet or the drug load in the non-disintegrating matrix-type controlled release system. It is an important task to evaluate the possible presence of a critical concentration, i.e. percolation threshold where the relevant component percolates the system. Thus, only formulations with concentration p, which are not too close to the pecolation threshold p_c, represent robust formulations.
机译:药物固体剂型(片剂,糖衣丸,胶囊剂)代表了市场上所有剂型的大部分。为了保证这些剂型的高质量,健壮的制剂是先决条件。因此,需要验证描述组成和过程的配方。由于药物制剂的复杂性,可能影响剂型质量的众多因素,有关药物粉末混合物使用的大多数知识都是基于经验发现的。渗流理论似乎为更合理地设计由颗粒物质组成的配方提供了关键。将提出两种典型的应用:快速崩解的水溶性片剂和不崩解的不可溶胀的基质型控释系统。渗流理论概念的应用在非常不同的领域,例如固体的相变,在无序介质中的扩散等,对快速崩解和非崩解的行为产生了重要的认识。固体剂型。渗流理论的基本方程式可在两种情况下应用。该方程是幂定律,它描述了接近渗流阈值p_c研究的系统的相关特性X,如下所示:X = S / p-p_c / q(1),S =比例因子,p =占用概率,q =临界指数颗粒系统中的占据概率通常对应于相关成分的浓度,例如快速崩解片剂中的崩解剂或非崩解基质型控释系统中的载药量。评估临界浓度的可能存在是一项重要的任务,即相关组件对系统进行渗透的渗透阈值。因此,只有浓度p不太接近渗透阈值p_c的制剂才代表稳健的制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号